Ferrari Richard 4

What Happened
Richard Ferrari, a director of Pulmonx Corp (LUNG), received a grant of 40,000 restricted stock units (RSUs) on June 5, 2026. The grant was reported at a $0.00 per-share acquisition price (total reported consideration $0). This is an award (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-06-05; Form 4 filed: 2026-06-09.
• Shares/units granted: 40,000 RSUs; reported acquisition price: $0.00; total reported consideration: $0.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: The RSUs vest on the earlier of (i) the one-year anniversary of the June 5, 2026 grant (or the next business day if June 5 is not a business day) or (ii) the date of the next year’s Annual Meeting of Stockholders (see footnote F1). The award is payable solely in common stock.
• No indication in the provided data that this was a 10b5-1 sale, tax-withholding surrender, or similar; this filing reports a grant (award).

Context
RSUs are a form of equity compensation that convert into shares upon vesting. Grants are common for directors and executives as part of compensation and do not by themselves signal buying or selling sentiment. Because these RSUs vest in the near term (by one year or the next annual meeting), they will convert to shares if the vesting condition is met.